We systematically reviewed the published literature
on the complications of closing wedge high tibial osteotomy for
the treatment of unicompartmental osteoarthritis of the knee. Publications
were identified using the Cochrane Library, MEDLINE, EMBASE and
CINAHL databases up to February 2012. We assessed randomised (RCTs), controlled
group clinical (CCTs) trials, case series in publications associated
with closing wedge osteotomy of the tibia in patients with osteoarthritis
of the knee and finally a Cochrane review. Many of these trials
included comparative studies (opening wedge
We analysed whether a high body mass index (BMI)
had a deleterious effect on outcome following autologous chondrocyte
implantation (ACI) or matrix-carried autologous chondrocyte implantation
(MACI) for the treatment of full-thickness chondral defects of the
knee from a subset of patients enrolled in the ACI vs MACI trial
at The Royal National Orthopaedic Hospital. The mean Modified Cincinnati scores (MCS) were significantly
higher (p <
0.001) post-operatively in patients who had an ideal
body weight (n = 53; 20 to 24.9 kg/m2) than in overweight
(n = 63; 25 to 30 kg/m2) and obese patients (n = 22;
>
30 kg/m2). At a follow-up of two years, obese patients
demonstrated no sustained improvement in the MCS. Patients with
an ideal weight experienced significant improvements as early as
six months after surgery (p = 0.007). In total, 82% of patients
(31 of 38) in the ideal group had a good or excellent result, compared
with 49% (22 of 45) of the overweight and 5.5% (one of 18) in the
obese group (p <
0.001). There was a significant negative relationship between
BMI and the MCS 24 months after surgery (r = -0.4, p = 0.001). This study demonstrates that obese patients have worse knee function
before surgery and experience no sustained benefit from ACI or MACI
at two years after surgery. There was a correlation between increasing
BMI and a lower MCS according to a linear regression analysis. On
the basis of our findings patient selection can be more appropriately
targeted.
The October 2012 Knee Roundup360 looks at: autologous chondrocytes and chondromalacia patellae; drilling the femoral tunnel at ACL reconstruction; whether we repair the radially torn lateral meniscus; factors associated with patellofemoral pain; mechanoreceptors and the allografted ACL; whether high tibial osteotomy can delay the need for knee replacement; return to sport after ACL reconstruction; tissue-engineered cartilage; and the benefits of yoga.
We continued a prospective longitudinal follow-up
study of 53 remaining patients who underwent open total meniscectomy
as adolescents and who at that time had no other intra-articular
pathology of the knee. Their clinical, radiological and patient-reported
outcomes are described at a mean follow-up of 40 years (33 to 50).
The cohort of patients who had undergone radiological evaluation
previously after 30 years were invited for clinical examination,
radiological evaluation and review using two patient-reported outcome
measures. A total of seven patients (13.2%) had already undergone total
knee replacement at the time of follow-up. A significant difference
was observed between the operated and non-operated knee in terms
of range of movement and osteoarthritis of the tibiofemoral joint,
indicating a greater than fourfold relative risk of osteoarthritis
at 40 years post-operatively. All patients were symptomatic as defined
by the Knee Injury and Osteoarthritis Outcome Score. This study represents the longest follow-up to date and it can
be concluded that meniscectomy leads to symptomatic osteoarthritis
of the knee later in life, with a resultant 132-fold increase in
the rate of total knee replacement in comparison to their geographical
and age-matched peers.
In a randomised controlled pragmatic trial we
investigated whether local infiltration analgesia would result in earlier
readiness for discharge from hospital after total knee replacement
(TKR) than patient-controlled epidural analgesia (PCEA) plus femoral
nerve block. A total of 45 patients with a mean age of 65 years
(49 to 81) received a local infiltration with a peri-articular injection
of bupivacaine, morphine and methylprednisolone, as well as adjuvant
analgesics. In 45 PCEA+femoral nerve blockade patients with a mean
age of 67 years (50 to 84), analgesia included a bupivacaine nerve
block, bupivacaine/hydromorphone PCEA, and adjuvant analgesics.
The mean time until ready for discharge was 3.2 days (1 to 14) in
the local infiltration group and 3.2 days (1.8 to 7.0) in the PCEA+femoral
nerve blockade group. The mean pain scores for patients receiving
local infiltration were higher when walking (p = 0.0084), but there
were no statistically significant differences at rest. The mean
opioid consumption was higher in those receiving local infiltration. The choice between these two analgesic pathways should not be
made on the basis of time to discharge after surgery. Most secondary
outcomes were similar, but PCEA+femoral nerve blockade patients
had lower pain scores when walking and during continuous passive
movement. If PCEA+femoral nerve blockade is not readily available, local
infiltration provides similar length of stay and similar pain scores
at rest following TKR. Cite this article:
The Oxford mobile-bearing unicompartmental knee
replacement (UKR) is an effective and safe treatment for osteoarthritis
of the medial compartment. The results in the lateral compartment
have been disappointing due to a high early rate of dislocation
of the bearing. A series using a newly designed domed tibial component
is reported. The first 50 consecutive domed lateral Oxford UKRs in 50 patients
with a mean follow-up of three years (2.0 to 4.3) were included.
Clinical scores were obtained prospectively and Kaplan-Meier survival
analysis was performed for different endpoints. Radiological variables
related to the position and alignment of the components were measured. One patient died and none was lost to follow-up. The cumulative
incidence of dislocation was 6.2% (95% confidence interval (CI)
2.0 to 17.9) at three years. Survival using revision for any reason
and aseptic revision was 94% (95% CI 82 to 98) and 96% (95% CI 85
to 99) at three years, respectively. Outcome scores, visual analogue
scale for pain and maximum knee flexion showed a significant improvement
(p <
0.001). The mean Oxford knee score was 43 ( Clinical results are excellent and short-term survival has improved
when compared with earlier series. The risk of dislocation remains
higher using a mobile-bearing UKR in the lateral compartment when
compared with the medial compartment. Patients should be informed
about this complication. To avoid dislocations, care must be taken
not to elevate the lateral joint line.
The April 2012 Knee Roundup360 looks at the torn ACL, ACL reconstruction, the risk of ACL rupture, the benefit of warm-ups before exercise, glucosamine and tibiofemoral osteoarthritis, sensitisation and sporting tendinopathy, pain relief after TKR, the long-term results of the Genesis I, the gender specific recovery times after TKR, and the accuracy of the orthopaedic eyeball
The Oxford unicompartmental knee replacement
(UKR) is an established treatment option in the management of symptomatic
end-stage medial compartmental osteoarthritis (MCOA), which works
well in the young and active patient. However, previous studies
have shown that it is reliable only in the presence of a functionally
intact anterior cruciate ligament (ACL). This review reports the
outcomes, at a mean of five years and a maximum of ten years, of 52
consecutive patients with a mean age of 51 years (36 to 57) who
underwent staged or simultaneous ACL reconstruction and Oxford UKR.
At the last follow-up (with one patient lost to follow-up), the
mean Oxford knee score was 41 ( In summary, ACL reconstruction and Oxford UKR gives good results
in patients with end-stage MCOA secondary to ACL deficiency.
The June 2012 Knee Roundup360 looks at: ACI and mosaicplasty; ACI after microfracture; exercise therapy and the degenerate medial meniscal tear; intra-articular bupivacaine or ropivacaine at knee arthroscopy; lateral trochlear inclination and patellofemoral osteoarthritis; bone loss and ACL reconstruction; assessing stability using the contralateral knee; tranexamic acid and a useful review of knee replacement.
Medium-term survivorship of the Oxford phase
3 unicompartmental knee replacement (UKR) has not yet been established
in an Asian population. We prospectively evaluated the outcome of
400 phase 3 Oxford UKRs in 320 Korean patients with a mean age at
the time of operation of 69 years (48 to 82). The mean follow-up
was 5.2 years (1 to 10). Clinical and radiological assessment was
carried out pre- and post-operatively. At five years, the mean Knee
Society knee and functional scores had increased significantly from
56.2 (30 to 91) pre-operatively to 87.2 (59 to 98) (p = 0.034) and
from 59.2 (30 to 93) to 88.3 (50 to 100) (p = 0.021), respectively.
The Oxford knee score increased from a mean of 25.8 (12 to 39) pre-operatively
to 39.8 (25 to 58) at five years (p = 0.038). The ten-year survival
rate was 94% (95% confidence interval 90.1 to 98.0). A total of
14 UKRs (3.5%) required revision. The most common reason for revision
was dislocation of the bearing in 12 (3%). Conversion to a total
knee replacement was required in two patients who developed osteoarthritis
of the lateral compartment. This is the largest published series of UKR in Korean patients.
It shows that the mid-term results after a minimally invasive Oxford
phase 3 UKR can yield satisfactory clinical and functional results
in this group of patients.
The purpose of this study was to undertake a
meta-analysis to determine whether there is lower polyethylene wear and
longer survival when using mobile-bearing implants in total knee
replacement when compared with fixed-bearing implants. Of 975 papers
identified, 34 trials were eligible for data extraction and meta-analysis
comprising 4754 patients (6861 knees). We found no statistically
significant differences between the two designs in terms of the incidence
of radiolucent lines, osteolysis, aseptic loosening or survival.
There is thus currently no evidence to suggest that the use of mobile-bearing
designs reduce polyethylene wear and prolong survival after total
knee replacement. Cite this article:
Compartment syndrome of the foot is usually associated with trauma, and if untreated may result in deformity and loss of function. We report a case of spontaneous compartment syndrome of the foot presenting with severe unremitting pain. The diagnosis was supported by measurements of compartment pressures and the symptoms resolved after surgical decompression. Spontaneous compartment syndrome in the leg has been described in a small number of cases, but there has been no previous report involving the foot. We believe that this case highlights the importance of suspecting a spontaneous compartment syndrome of the foot if the appropriate symptoms are present but there is no clear cause. We also believe that compartment pressure measurement assists in the decision to undertake surgical decompression.
The Oxford knee score (OKS) is a validated and
widely accepted disease-specific patient-reported outcome measure,
but there is limited evidence regarding any long-term trends in
the score. We reviewed 5600 individual OKS questionnaires (1547
patients) from a prospectively-collected knee replacement database,
to determine the trends in OKS over a ten-year period following
total knee replacement. The mean OKS pre-operatively was 19.5 (95%
confidence interval (CI) 18.8 to 20.2). The maximum post-operative
OKS was observed at two years (mean score 34.4 (95% CI 33.7 to 35.2)),
following which a gradual but significant decline was observed through
to the ten-year assessment (mean score 30.1 (95% CI 29.1 to 31.1))
(p <
0.001). A similar trend was observed for most of the individual
OKS components (p <
0.001). Kneeling ability initially improved
in the first year but was then followed by rapid deterioration (p
<
0.001). Pain severity exhibited the greatest improvement, although
residual pain was reported in over two-thirds of patients post-operatively,
and peak improvement in the night pain component did not occur until
year four. Post-operative OKS was lower for women (p <
0.001),
those aged <
60 years (p <
0.003) and those with a body mass
index >
35 kg/m2 (p <
0.014), although similar changes
in scores were observed. This information may assist surgeons in
advising patients of their expected outcomes, as well as providing
a comparative benchmark for evaluating longer-term outcomes following
knee replacement. Cite this article:
We retrospectively reviewed 30 two-stage revision
procedures in 28 patients performed for fungal peri-prosthetic joint
infection (PJI) after a primary total knee replacement. Patients were
followed for at least two years or until the infection recurred.
The mean follow-up for patients who remained free of infection was
4.3 years (2.3 to 6.1). Overall, 17 patients were assessed as American
Society of Anesthesiologists grade 3 or 4. The surgical protocol included
removal of the infected implant, vigorous debridement and insertion
of an articulating cement spacer. This was followed by at least
six weeks of antimicrobial treatment and delayed reimplantation
in all patients. The mean interval between removal of the prosthesis
and reimplantation was 9.5 weeks (6 to 24). After reimplantation,
patients took antifungal agents orally for a maximum of six months. Fungal PJIs can be treated successfully by removal of all infected
material, appropriate antimicrobial treatment and delayed reimplantation.
A total of 445 consecutive primary total knee
replacements (TKRs) were followed up prospectively at six and 18 months
and three, six and nine years. Patients were divided into two groups:
non-obese (body mass index (BMI) <
30 kg/m2) and obese
(BMI ≥ 30 kg/m2). The obese group was subdivided into
mildly obese (BMI 30 to 35 kg/m2) and highly obese (BMI ≥ 35
kg/m2) in order to determine the effects of increasing
obesity on outcome. The clinical data analysed included the Knee
Society score, peri-operative complications and implant survival.
There was no difference in the overall complication rates or implant
survival between the two groups. Obesity appears to have a small but significant adverse effect
on clinical outcome, with highly obese patients showing lower function
scores than non-obese patients. However, significant improvements
in outcome are sustained in all groups nine years after TKR. Given
the substantial, sustainable relief of symptoms after TKR and the low
peri-operative complication and revision rates in these two groups,
we have found no reason to limit access to TKR in obese patients.
The purpose of this study was to measure the
radiological parameters of femoral component alignment of the Oxford
Phase 3 unicompartmental knee replacement (UKR), and evaluate their
effect on clinical outcome. Multiple regression analysis was used
to examine the relative contributions of the radiological assessment
of femoral component alignment in 189 consecutive UKRs performed
by a single surgeon. The American Knee Society scores were compared
between groups, defined as being within or outside recommended tolerances
of the position of the femoral component. For the flexion/extension
position 21 UKRs (11.1%) lay outside the recommended limits, and for
posterior overhang of the femoral component nine (4.8%) lay outside
the range. The pre-operative hip/knee/ankle (HKA) angle, narrowest
canal distance from the distal femoral entry point of the alignment
jig and coronal entry-point position had significant effects on
the flexion/extension position. Pre-operative HKA angle had a significant
influence on posterior overhang of the femoral component. However,
there was no significant difference in American Knee Society scores
relative to the position of the femoral component.
Lower limb muscle power is thought to influence outcome following
total knee replacement (TKR). Post-operative deficits in muscle
strength are commonly reported, although not explained. We hypothesised
that post-operative recovery of lower limb muscle power would be
influenced by the number of satellite cells in the quadriceps muscle at
time of surgery. Biopsies were obtained from 29 patients undergoing TKR. Power
output was assessed pre-operatively and at six and 26 weeks post-operatively
with a Leg Extensor Power Rig and data were scaled for body weight.
Satellite cell content was assessed in two separate analyses, the
first cohort (n = 18) using immunohistochemistry and the second
(n = 11) by a new quantitative polymerase chain reaction (q-PCR)
protocol for Pax-7 (generic satellite cell marker) and Neural Cell
Adhesion Molecule (NCAM; marker of activated cells).Objectives
Methods
Intrapelvic migration of the acetabular component of a total hip replacement, with severe acetabular destruction making reconstruction impossible, is very rare. We present a patient in whom the component was removed using a laparotomy and a transperitoneal approach with subsequent salvage using a saddle prosthesis and a total femoral replacement.
There has been debate about the role of unicompartmental knee replacement in the presence of radiologically identifiable degenerative changes of the patellofemoral joint. We studied 195 knees in 163 patients in whom an Oxford unicompartmental knee replacement had been performed for medial osteoarthritis between January 2004 and July 2007. The mean age of the patients was 66 years (51 to 93). The degree of degenerative change of the patellofemoral joint was assessed using Jones’ criteria. Functional outcome was assessed at a mean of 3.4 years (2 to 7) post-operatively, using the Oxford knee score and the Short-form 12 score. Degenerative changes of the patellofemoral joint were seen pre-operatively in 125 knees (64%) on the skyline radiographs. There was no statistically significant difference in the Oxford knee or Short-form 12 scores between those patients who had patellofemoral osteoarthritis pre-operatively and those who did not (p = 0.22 and 0.54, respectively). These results support the opinion expressed at the designer’s hospital that degenerative changes of the patellofemoral joint in isolation should not be considered to be a contraindication to medial Oxford unicompartmental knee replacement.
The objective of this study was to compare the early migration
characteristics and functional outcome of the Triathlon cemented
knee prosthesis with its predecessor, the Duracon cemented knee
prosthesis (both Stryker). A total 60 patients were prospectively randomised and tibial
component migration was measured by radiostereometric analysis (RSA)
at three months, one year and two years; clinical outcome was measured
by the American Knee Society score and the Knee Osteoarthritis and
Injury Outcome Score.Objectives
Methods